Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels
Haematologica
.
2020 Apr;105(4):e169-e171.
doi: 10.3324/haematol.2019.224360.
Epub 2019 Aug 8.
Authors
Jennifer L J Heaney
1
,
Alex Richter
1
,
Stella Bowcock
2
,
Guy Pratt
3
,
J Anthony Child
4
,
Graham Jackson
5
,
Gareth Morgan
6
,
Ingemar Turesson
7
,
Mark T Drayson
8
Affiliations
1
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
2
King's College Hospital NHS Trust, London, UK.
3
University Hospitals Birmingham NHS Trust, Birmingham, UK.
4
University of Leeds, Leeds, UK.
5
University of Newcastle, Newcastle, UK.
6
Perlmutter Cancer Center, New York, NY, USA.
7
Lund University, Lund, Sweden.
8
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK m.t.drayson@bham.ac.uk.
PMID:
31399530
PMCID:
PMC7109726
DOI:
10.3324/haematol.2019.224360
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Immunoglobulin Light Chains*
Immunoglobulins*
Multiple Myeloma* / diagnosis
Substances
Immunoglobulin Light Chains
Immunoglobulins
M-proteins (Myeloma)
Grants and funding
G0100132/MRC_/Medical Research Council/United Kingdom